This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Moses D. Sekaran: Innovating Anti-HIV Antibody Responses
Introduction
Moses D. Sekaran, based in Durham, NC, is a notable inventor recognized for his contributions to the field of immunology, specifically in the fight against HIV. With a noteworthy patent to his name, he has made strides in the induction of broadly neutralizing antibody responses, showcasing the significant impact of his work.
Latest Patents
Moses D. Sekaran holds a patent titled "Methods for the induction of broadly anti-HIV-1 neutralizing antibody responses employing liposome-MPER peptide compositions." This groundbreaking invention pertains to formulations designed to elicit anti-HIV-1 antibodies. The patent emphasizes the use of Toll Like Receptor (TLR) agonists alongside HIV-1 gp41 membrane proximal external region (MPER) peptide-liposome conjugates. His innovative methods aim to enhance the induction of broadly reactive anti-HIV-1 antibodies, potentially paving the way for new therapeutic avenues.
Career Highlights
Moses D. Sekaran is affiliated with Duke University, where he continues to advance research in immunology. His patent reflects his commitment to developing novel strategies in healthcare that could alter the landscape of HIV treatment. This represents a significant achievement in his career, illustrating his expertise and dedication to scientific innovation.
Collaborations
Throughout his career, Sekaran has collaborated with esteemed coworkers such as S. Munir Alam and Barton F. Haynes. These partnerships within Duke University foster an environment of collaborative research, fueling creativity and leading to new findings in the realm of HIV research and immunology.
Conclusion
Moses D. Sekaran’s work presents a critical advancement in how anti-HIV-1 neutralizing antibody responses can be induced. His innovative approach, detailed in his patent, signifies a step forward in the global fight against HIV. With continued research and collaboration, Sekaran is positioned to contribute significantly to the future of immunology and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile